Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Bando

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Journal of Gastroenterology|May 25, 2026
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancerTaro Shibuki, Celine Hoyek, Ryne Ramaker, et al.
British Journal of Cancer|August 2, 2023
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)Koji Ando, Yoshiaki Nakamura, Hiroyuki Kitao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Circulating Tumor DNA Analysis Detects <i>FGFR2</i> Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric CancerTomoko Jogo, Yoshiaki Nakamura, Kohei Shitara, et al.
Nature Communications|August 14, 2025
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancerChiara M L Loeffler, Hideaki Bando, Srividhya Sainath, et al.
Cancer Science|June 2, 2025
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 StudyTadayoshi Hashimoto, Naoko Iida, Yoshiaki Nakamura, et al.
Nature Cancer|February 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)Hideaki Bando, Shogo Kumagai, Daisuke Kotani, et al.
Nature Medicine|September 16, 2024
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumorsYoshiaki Nakamura, Hiroshi Ozaki, Makoto Ueno, et al.
Annals of Surgery|September 26, 2025
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort StudyKoji Ando, Atsushi Hamabe, Yoshiaki Nakamura, et al.
JCO Precision Oncology|August 1, 2025
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological FactorsAmane Jubashi, Izuma Nakayama, Naoya Sakamoto, et al.
NPJ Precision Oncology|April 30, 2026
Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resectionHidekazu Oyoshi, Hideaki Bando, Riu Yamashita, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Journal of Gastroenterology|May 25, 2026
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancerTaro Shibuki, Celine Hoyek, Ryne Ramaker, et al.
British Journal of Cancer|August 2, 2023
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)Koji Ando, Yoshiaki Nakamura, Hiroyuki Kitao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Circulating Tumor DNA Analysis Detects <i>FGFR2</i> Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric CancerTomoko Jogo, Yoshiaki Nakamura, Kohei Shitara, et al.
Nature Communications|August 14, 2025
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancerChiara M L Loeffler, Hideaki Bando, Srividhya Sainath, et al.
Cancer Science|June 2, 2025
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 StudyTadayoshi Hashimoto, Naoko Iida, Yoshiaki Nakamura, et al.
Nature Cancer|February 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)Hideaki Bando, Shogo Kumagai, Daisuke Kotani, et al.
Nature Medicine|September 16, 2024
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumorsYoshiaki Nakamura, Hiroshi Ozaki, Makoto Ueno, et al.
Annals of Surgery|September 26, 2025
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort StudyKoji Ando, Atsushi Hamabe, Yoshiaki Nakamura, et al.
JCO Precision Oncology|August 1, 2025
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological FactorsAmane Jubashi, Izuma Nakayama, Naoya Sakamoto, et al.
NPJ Precision Oncology|April 30, 2026
Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resectionHidekazu Oyoshi, Hideaki Bando, Riu Yamashita, et al.
Pageof 19